Related Experiment Video
Updated: Apr 2, 2026

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
Circ-ZBTB38 as an oncogenic circular RNA: Mechanisms in disrupting RalGAP complexes and its clinical value in
Wanqi Zhang1, Nan Yang2, Yuekai Wang3
1Department of Plastic & Cosmetic Surgery, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China; Department of Teaching and Experimental Center, College of Basic Medical Sciences, Army Medical University (Third Military Medical University), Chongqing, 400038, China.
Objective:
Circular RNAs (circRNAs) hold significant potential both in the regulation of tumor progression and in clinical applications for tumors. This study aims to investigate the functional mechanism of circ-ZBTB38 in melanoma progression as well as its potential clinical application value.
Methods:
Differentially expressed circRNAs in melanoma were screened from the GSE138412 dataset and validated by circBase, qPCR, and Sanger sequencing. Gain- and loss-of-function experiments were performed to assess the function of circ-ZBTB38. Molecular interactions were validated through RNA pull-down, mass spectrometry, and RIP assays; binding regions were characterized by RNAfold WebServer analysis and RNA-segment pull-down assays. Functional and regulatory mechanisms within the circ-ZBTB38/RALGAPB axis were evaluated using qPCR, ubiquitination assays, western blotting, proliferation assays, and Transwell migration/invasion assays. The potential clinical application value was explored via interfering with circ-ZBTB38 expression in mouse models and tissue microarray analysis of 80 paired specimens. The stability of circ-ZBTB38 was confirmed by RNase R digestion and actinomycin D (ActD) decay assays.
Results:
We identified circ-ZBTB38 as an oncogenic circular RNA up-regulated in melanoma tissues and cell lines. Functional assays demonstrated that circ-ZBTB38 promoted melanoma cell proliferation and migration. Mechanistically, circ-ZBTB38 bound RALGAPB through its backsplicing site, accelerating its ubiquitination degradation, subsequently disrupted the catalytic subunit of RalGAPs. Clinically, high circ-ZBTB38 expression was correlated with a worse prognosis. Interfering with circ-ZBTB38 expression in vivo can significantly inhibit tumor growth and metastasis, and prolong the survival of mice.
Conclusions:
We have established the circ-ZBTB38/RALGAPB axis as a novel regulatory circuit in melanoma. Circ-ZBTB38 mediates RALGAPB post-translational degradation to hyperactivate Ral signaling. This work uncovers a new mechanism of circRNA-mediated regulation of enzyme activity (RalGAPs) in signaling crosstalk and highlights circ-ZBTB38 as a prognostic biomarker and therapeutic target for melanoma.
Insights
Circular RNAs (circRNAs) like circ-ZBTB38 promote melanoma by degrading RALGAP B, disrupting Ral signaling. Targeting circ-ZBTB38 offers a new therapeutic strategy for melanoma patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer progression.
- circRNAs have potential as diagnostic and therapeutic targets in various tumors.
- The specific function of circ-ZBTB38 in melanoma remains largely unexplored.
Purpose of the Study:
- To investigate the functional mechanism of circ-ZBTB38 in melanoma.
- To explore the clinical application value of circ-ZBTB38 in melanoma.
- To elucidate the circ-ZBTB38/RALGAPB regulatory axis in melanoma.
Main Methods:
- Bioinformatic screening of differentially expressed circRNAs from the GSE138412 dataset.
- Validation using circBase, qPCR, Sanger sequencing, and RNase R digestion.
- Functional assays including gain- and loss-of-function experiments, proliferation, migration, and invasion assays.
- Mechanistic studies involving RNA pull-down, mass spectrometry, RIP assays, ubiquitination assays, and western blotting.
- In vivo studies using mouse models and clinical correlation analysis via tissue microarrays.
Main Results:
- circ-ZBTB38 was identified as an oncogenic circRNA, significantly upregulated in melanoma tissues and cell lines.
- circ-ZBTB38 overexpression promoted melanoma cell proliferation, migration, and invasion.
- Mechanistically, circ-ZBTB38 binds to RALGAPB, promoting its ubiquitination and degradation, leading to hyperactivation of Ral signaling.
- High circ-ZBTB38 expression correlated with poor prognosis in melanoma patients.
- Inhibition of circ-ZBTB38 in vivo suppressed tumor growth, metastasis, and improved survival in mice.
Conclusions:
- circ-ZBTB38 acts as an oncogene in melanoma by mediating RALGAPB post-translational degradation and activating Ral signaling.
- The circ-ZBTB38/RALGAPB axis represents a novel regulatory circuit in melanoma.
- circ-ZBTB38 is a potential prognostic biomarker and therapeutic target for melanoma.
More Related Videos
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

